Claims for Patent: 7,795,293

Summary for Patent: 7,795,293

Title:	3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
Abstract:	An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-- ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid.
Inventor(s):	Moore; Stephen (Tonbridge, GB)
Assignee:	GlaxoSmithKline LLC (Philadelphia, PA)
Application Number:	12/472,819
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,795,293
Patent Claims:	1. A method of enhancing platelet production in a human in need thereof which comprises administering to such human an effective amount of the compound 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-p- yrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine). 2. The method of claim 1 wherein the compound is administered orally. 3. The method of claim 1 wherein the compound is administered parenterally.